Laronidase en es it fr

Laronidase Brand names, Laronidase Analogs

Laronidase Brand Names Mixture

  • No information avaliable

Laronidase Chemical_Formula


Laronidase RX_link

Laronidase fda sheet

Laronidase msds (material safety sheet)

Laronidase Synthesis Reference

No information avaliable

Laronidase Molecular Weight


Laronidase Melting Point

Mandelli J, Wajner A, Pires R, Giugliani R, Coelho JC. Detection of mucopolysaccharidosis type I heterozygotes on the basis of the biochemical properties of plasma alpha-L-iduronidase. Clin Chim Acta. 2001 Oct;312(1-2):81-6.

Laronidase H2O Solubility

No information avaliable

Laronidase State


Laronidase LogP


Laronidase Dosage Forms

Solution (IV infusion)

Laronidase Indication

For the treatment of mucopolysaccharidosis

Laronidase Pharmacology

Laronidase is used to treat mucopolysaccharide storage disorders (specifically mucopolysaccharidosis 1 or Hurlers syndrome) caused by deficiencies of alpha-L-iduronidase. Reduced or absent a-L-iduronidase activity results in the accumulation of the GAG substrates, dermatan sulfate and heparan sulfate, throughout the body and leads to widespread cellular, tissue, and organ dysfunction.

Laronidase Absorption

No information avaliable

Laronidase side effects and Toxicity

No information avaliable

Laronidase Patient Information

No information avaliable

Laronidase Organisms Affected

Humans and other mammals